These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27027982)

  • 21. Implantable Cardioverter-Defibrillators With Versus Without Resynchronization Therapy in Patients With a QRS Duration >180 ms.
    Sundaram V; Sahadevan J; Waldo AL; Stukenborg GJ; Reddy YNV; Asirvatham SJ; Mackall JA; Intini A; Wilson B; Simon DI; Bilchick KC
    J Am Coll Cardiol; 2017 Apr; 69(16):2026-2036. PubMed ID: 28427578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
    Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
    J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of QRS duration on outcome of death or appropriate defibrillator therapy by strategy of left ventricular lead placement in cardiac resynchronization therapy recipients.
    Saba S; Marek J; Alam MB; Adelstein E; Schwartzman D; Jain S; Gorcsan J
    J Interv Card Electrophysiol; 2014 Dec; 41(3):211-5. PubMed ID: 25391355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data.
    Zusterzeel R; Selzman KA; Sanders WE; Caños DA; O'Callaghan KM; Carpenter JL; Piña IL; Strauss DG
    JAMA Intern Med; 2014 Aug; 174(8):1340-8. PubMed ID: 25090172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. QRS axis and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT.
    Brenyo A; Rao M; Barsheshet A; Cannom D; Quesada A; McNitt S; Huang DT; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2013 Apr; 24(4):442-8. PubMed ID: 23252875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival with cardiac-resynchronization therapy in mild heart failure.
    Goldenberg I; Kutyifa V; Klein HU; Cannom DS; Brown MW; Dan A; Daubert JP; Estes NA; Foster E; Greenberg H; Kautzner J; Klempfner R; Kuniss M; Merkely B; Pfeffer MA; Quesada A; Viskin S; McNitt S; Polonsky B; Ghanem A; Solomon SD; Wilber D; Zareba W; Moss AJ
    N Engl J Med; 2014 May; 370(18):1694-701. PubMed ID: 24678999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modeling defibrillation benefit for survival among cardiac resynchronization therapy defibrillator recipients.
    Bilchick KC; Wang Y; Curtis JP; Cheng A; Dharmarajan K; Shadman R; Dardas TF; Anand I; Lund LH; Dahlström U; Sartipy U; Maggioni A; O'Connor C; Levy WC
    Am Heart J; 2020 Apr; 222():93-104. PubMed ID: 32032927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of QRS morphology and duration on outcomes after cardiac resynchronization therapy: Results from the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT).
    Birnie DH; Ha A; Higginson L; Sidhu K; Green M; Philippon F; Thibault B; Wells G; Tang A
    Circ Heart Fail; 2013 Nov; 6(6):1190-8. PubMed ID: 23995437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes in cardiac resynchronization therapy-defibrillator recipients 80 years of age and older.
    Adelstein EC; Liu J; Jain S; Schwartzman D; Althouse AD; Wang NC; Gorcsan J; Saba S
    Europace; 2016 Mar; 18(3):420-7. PubMed ID: 26487669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes and predictive value of dispersion of repolarization parameters for appropriate therapy in patients with biventricular implantable cardioverter-defibrillators.
    Lellouche N; De Diego C; Akopyan G; Boyle NG; Mahajan A; Cesario DA; Wiener I; Shivkumar K
    Heart Rhythm; 2007 Oct; 4(10):1274-83. PubMed ID: 17905332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.
    Wilcox JE; Fonarow GC; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
    Circ Heart Fail; 2014 Jan; 7(1):146-53. PubMed ID: 24178311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
    Healey JS; Hohnloser SH; Exner DV; Birnie DH; Parkash R; Connolly SJ; Krahn AD; Simpson CS; Thibault B; Basta M; Philippon F; Dorian P; Nair GM; Sivakumaran S; Yetisir E; Wells GA; Tang AS;
    Circ Heart Fail; 2012 Sep; 5(5):566-70. PubMed ID: 22896584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effectiveness of CRT on improvement of survival of heart failure patients in real life clinical settings.
    Hudak M; Kerekanic M; Misikova S; Komanova E; Boho A; Stancak B
    Acta Cardiol; 2017 Apr; 72(2):180-187. PubMed ID: 28597793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absolute survival after cardiac resynchronization therapy according to baseline QRS duration: a multinational 10-year experience: data from the Multicenter International CRT Study.
    Gasparini M; Leclercq C; Yu CM; Auricchio A; Steinberg JS; Lamp B; Klersy C; Leyva F
    Am Heart J; 2014 Feb; 167(2):203-209.e1. PubMed ID: 24439981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry.
    Morani G; Gasparini M; Zanon F; Casali E; Spotti A; Reggiani A; Bertaglia E; Solimene F; Molon G; Accogli M; Tommasi C; Paoletti Perini A; Ciardiello C; Padeletti L
    Europace; 2013 Sep; 15(9):1273-9. PubMed ID: 23439866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial.
    Lee AY; Kutyifa V; Ruwald MH; McNitt S; Polonsky B; Zareba W; Moss AJ; Ruwald AC
    Heart Rhythm; 2015 Sep; 12(9):2010-7. PubMed ID: 26025322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
    Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ;
    Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy).
    Ruwald MH; Ruwald AC; Jons C; Alexis J; McNitt S; Zareba W; Moss AJ
    J Am Coll Cardiol; 2013 Apr; 61(14):1518-26. PubMed ID: 23500269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrioventricular delay programming and the benefit of cardiac resynchronization therapy in MADIT-CRT.
    Brenyo A; Kutyifa V; Moss AJ; Mathias A; Barsheshet A; Pouleur AC; Knappe D; McNitt S; Polonsky B; Huang DT; Solomon SD; Zareba W; Goldenberg I
    Heart Rhythm; 2013 Aug; 10(8):1136-43. PubMed ID: 23712031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac Resynchronization Therapy and Clinical Outcomes in Continuous Flow Left Ventricular Assist Device Recipients.
    Gopinathannair R; Roukoz H; Bhan A; Ravichandran A; Ahmed MM; Familtsev D; Bhat G; Cowger J; Abdullah M; Sandesara C; Dhawan R; Birks EJ; Trivedi JR; Slaughter MS
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29907652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.